ProShare Advisors
WVE icon

ProShare Advisors’s Wave Life Sciences WVE Stock Holding History

ProShare Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Sell
24,374
-4,304
-15% -$28.5K ﹤0.01% 1727
2026
Q1 		$208K Buy
28,678
+142
+0.5% +$1.85K ﹤0.01% 1554
2025
Q4 		$485K Buy
28,536
+3,701
+15% +$37.6K ﹤0.01% 1142
2025
Q3 		$182K Sell
24,835
-3,904
-14% -$31.6K ﹤0.01% 1714
2025
Q2 		$187K Buy
28,739
+959
+3% +$6.33K ﹤0.01% 1741
2025
Q1 		$224K Sell
27,780
-5,404
-16% -$59.1K ﹤0.01% 1614
2024
Q4 		$410K Sell
33,184
-10,820
-25% -$144K ﹤0.01% 1400
2024
Q3 		$361K Buy
44,004
+26,594
+153% +$159K ﹤0.01% 1340
2024
Q2 		$86.9K Sell
17,410
-4,354
-20% -$24.8K ﹤0.01% 1686
2024
Q1 		$134K Buy
21,764
+5,648
+35% +$28.3K ﹤0.01% 1766
2023
Q4 		$81.4K Buy
16,116
+1,964
+14% +$10.5K ﹤0.01% 1807
2023
Q3 		$81.4K Buy
14,152
+96
+0.7% +$438 ﹤0.01% 1665
2023
Q2 		$51.2K Buy
+14,056
New +$56.8K ﹤0.01% 1771
2022
Q2 		– Sell
-14,386
Closed -$28K – 2155
2022
Q1 		$28K Sell
14,386
-3,568
-20% -$8.74K ﹤0.01% 2159
2021
Q4 		$57K Buy
17,954
+2,211
+14% +$9.18K ﹤0.01% 2270
2021
Q3 		$77K Sell
15,743
-2,947
-16% -$17.9K ﹤0.01% 1942
2021
Q2 		$124K Buy
18,690
+3,154
+20% +$20.6K ﹤0.01% 2260
2021
Q1 		$87K Buy
15,536
+747
+5% +$7.18K ﹤0.01% 2181
2020
Q4 		$116K Buy
+14,789
New +$124K ﹤0.01% 1968
2020
Q1 		– Sell
-10,468
Closed -$84K – 1606
2019
Q4 		$84K Sell
10,468
-1,377
-12% -$33.8K ﹤0.01% 1712
2019
Q3 		$243K Sell
11,845
-301
-2% -$6.9K ﹤0.01% 1328
2019
Q2 		$317K Sell
12,146
-1,424
-10% -$39.9K ﹤0.01% 1211
2019
Q1 		$527K Buy
13,570
+1,726
+15% +$70K ﹤0.01% 1000
2018
Q4 		$498K Buy
+11,844
New +$527K ﹤0.01% 953

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

ProShare Advisors's WVE Position: Q2 2026 in Review

ProShare Advisors reduced its Wave Life Sciences (WVE) stake by 15% in Q2 2026, selling an estimated $28.5K and leaving 24,374 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1727.

ProShare Advisors first reported a position in WVE in Q4 2018 and has held it in 24 quarters since. The position peaked at $527K in Q1 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • ProShare Advisors held 24,374 shares of Wave Life Sciences worth $142K as of Q2 2026.
  • ProShare Advisors sold 4,304 Wave Life Sciences shares in Q2 2026, an estimated $28.5K.
  • Wave Life Sciences made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1727 holding.
  • ProShare Advisors first reported a position in Wave Life Sciences in Q4 2018 and has held it in 24 quarters since.
  • ProShare Advisors's Wave Life Sciences position peaked at $527K in Q1 2019.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.